Outcomes of Fractional Flow Reserve-guided Deferred Coronary Revascularization

Context: Fractional flow reserve (FFR) is used to assess the functional significance of intermediate coronary stenosis. An FFR value of 0.80 or less identifies significant lesions, whereas higher values do not require revascularization. The rate of deferred lesion revascularization (DLR) differs amo...

Full description

Saved in:
Bibliographic Details
Main Authors: Mohammad Reza Beyranvand, Mehdi Sheibani, Hana Mirzabeigi, Hootan Manhoobi
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2024-10-01
Series:Heart Views
Subjects:
Online Access:https://journals.lww.com/10.4103/heartviews.heartviews_76_24
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850225348418994176
author Mohammad Reza Beyranvand
Mehdi Sheibani
Hana Mirzabeigi
Hootan Manhoobi
author_facet Mohammad Reza Beyranvand
Mehdi Sheibani
Hana Mirzabeigi
Hootan Manhoobi
author_sort Mohammad Reza Beyranvand
collection DOAJ
description Context: Fractional flow reserve (FFR) is used to assess the functional significance of intermediate coronary stenosis. An FFR value of 0.80 or less identifies significant lesions, whereas higher values do not require revascularization. The rate of deferred lesion revascularization (DLR) differs among studies. Aims: This study aims to evaluate the outcome of deferring revascularization in intermediate coronary stenoses in angiography with nonischemic values in FFR assessment. Settings and Design: This study was conducted in a single center from March 2013 to August 2017. Subjects and Methods: The study involved patients diagnosed with moderate (50%–69%) coronary stenosis and noninfarcted FFR (>0.8). All patients were followed up, and total mortality and DLR were recorded. Statistical Analysis Used: Fisher exact statistical test was used to compare descriptive variables, and the Mann–Whitney statistical test was used for quantitative variables. Results: There were 115 patients with a mean age of 58.35 ± 10.07 years; 71 (61.7%) were male. The mean (range) follow-up period was 32 ± 15 (6–60) months. The mortality rate was 0.8%, and 4.8% of patients had revascularization during the follow-up period. Conclusions: Deferring revascularization and medical management for intermediate coronary lesions with nonischemic FFR (>0.8) are a safe strategy.
format Article
id doaj-art-39fe6cb5b9b0445d877f5b0d649b1c48
institution OA Journals
issn 1995-705X
0976-5123
language English
publishDate 2024-10-01
publisher Wolters Kluwer Medknow Publications
record_format Article
series Heart Views
spelling doaj-art-39fe6cb5b9b0445d877f5b0d649b1c482025-08-20T02:05:23ZengWolters Kluwer Medknow PublicationsHeart Views1995-705X0976-51232024-10-0125422322810.4103/heartviews.heartviews_76_24Outcomes of Fractional Flow Reserve-guided Deferred Coronary RevascularizationMohammad Reza BeyranvandMehdi SheibaniHana MirzabeigiHootan ManhoobiContext: Fractional flow reserve (FFR) is used to assess the functional significance of intermediate coronary stenosis. An FFR value of 0.80 or less identifies significant lesions, whereas higher values do not require revascularization. The rate of deferred lesion revascularization (DLR) differs among studies. Aims: This study aims to evaluate the outcome of deferring revascularization in intermediate coronary stenoses in angiography with nonischemic values in FFR assessment. Settings and Design: This study was conducted in a single center from March 2013 to August 2017. Subjects and Methods: The study involved patients diagnosed with moderate (50%–69%) coronary stenosis and noninfarcted FFR (>0.8). All patients were followed up, and total mortality and DLR were recorded. Statistical Analysis Used: Fisher exact statistical test was used to compare descriptive variables, and the Mann–Whitney statistical test was used for quantitative variables. Results: There were 115 patients with a mean age of 58.35 ± 10.07 years; 71 (61.7%) were male. The mean (range) follow-up period was 32 ± 15 (6–60) months. The mortality rate was 0.8%, and 4.8% of patients had revascularization during the follow-up period. Conclusions: Deferring revascularization and medical management for intermediate coronary lesions with nonischemic FFR (>0.8) are a safe strategy.https://journals.lww.com/10.4103/heartviews.heartviews_76_24angiographycoronary physiologycoronary stenosisfractional flow reserve
spellingShingle Mohammad Reza Beyranvand
Mehdi Sheibani
Hana Mirzabeigi
Hootan Manhoobi
Outcomes of Fractional Flow Reserve-guided Deferred Coronary Revascularization
Heart Views
angiography
coronary physiology
coronary stenosis
fractional flow reserve
title Outcomes of Fractional Flow Reserve-guided Deferred Coronary Revascularization
title_full Outcomes of Fractional Flow Reserve-guided Deferred Coronary Revascularization
title_fullStr Outcomes of Fractional Flow Reserve-guided Deferred Coronary Revascularization
title_full_unstemmed Outcomes of Fractional Flow Reserve-guided Deferred Coronary Revascularization
title_short Outcomes of Fractional Flow Reserve-guided Deferred Coronary Revascularization
title_sort outcomes of fractional flow reserve guided deferred coronary revascularization
topic angiography
coronary physiology
coronary stenosis
fractional flow reserve
url https://journals.lww.com/10.4103/heartviews.heartviews_76_24
work_keys_str_mv AT mohammadrezabeyranvand outcomesoffractionalflowreserveguideddeferredcoronaryrevascularization
AT mehdisheibani outcomesoffractionalflowreserveguideddeferredcoronaryrevascularization
AT hanamirzabeigi outcomesoffractionalflowreserveguideddeferredcoronaryrevascularization
AT hootanmanhoobi outcomesoffractionalflowreserveguideddeferredcoronaryrevascularization